Krishna Institute of Medical Sciences · NSE: KIMS · BSE: 543308
Q1 FY25 results · Apr–Jun 2024
Krishna Institute of Medical Sciences reported revenue from operations of ₹688.40 crore (up 13.6% from Q1 FY24) and net profit of ₹95.20 crore (up 9.8% from Q1 FY24) for Q1 FY25 (Apr–Jun 2024), on a consolidated basis.
| Item | Q1 FY25 | Q1 FY24 | YoY | Q4 FY24 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 688.40 | 606.03 | +13.6% | 633.80 | +8.6% |
| Other income | 4.60 | 3.11 | +47.8% | 3.81 | +20.8% |
| Total income | 693.00 | 609.14 | +13.8% | 637.60 | +8.7% |
| Profit before tax | 127.10 | 118.58 | +7.2% | 100.12 | +26.9% |
| Net profit for the period | 95.20 | 86.67 | +9.8% | 71.49 | +33.2% |
| Attributable to shareholders of the company | 86.60 | 80.81 | +7.2% | 65.47 | +32.3% |
| EPS, basic (₹) | 10.82 | 10.10 | +7.1% | 8.18 | +32.3% |
| Net margin (%) | 13.8 | 14.3 | 11.3 |
| Item | Q1 FY25 | Q1 FY24 | YoY | Q4 FY24 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 327.40 | 298.90 | +9.5% | 304.85 | +7.4% |
| Other income | 5.30 | 3.84 | +38.1% | 3.90 | +36.0% |
| Total income | 332.70 | 302.74 | +9.9% | 308.74 | +7.8% |
| Profit before tax | 81.60 | 83.98 | −2.8% | 67.47 | +20.9% |
| Net profit for the period | 60.70 | 62.63 | −3.1% | 48.19 | +25.9% |
| EPS, basic (₹) | 7.58 | 7.83 | −3.2% | 6.02 | +25.9% |
| Net margin (%) | 18.5 | 21.0 | 15.8 |
Consolidated
- Filed with BSE
- 08 Aug 2024, 11:41 IST
- Board meeting
- 07 Aug 2024
- Period
- 01 Apr 2024 to 30 Jun 2024
- Review status
- Unaudited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 08 Aug 2024, 11:41 IST
- Board meeting
- 07 Aug 2024
- Period
- 01 Apr 2024 to 30 Jun 2024
- Review status
- Unaudited
- Source
- XBRL filing on BSE